Print this page    •   Back to Web version of article

U.S. News
Georgia: Emory Snags $6 Million for HIV/AIDS Vaccine Research

September 21, 2012

The Bill & Melinda Gates Foundation has awarded Emory University a $6 million grant as part of the Collaboration for AIDS Vaccine Discovery (CAVD). The Collaboration, an international network of experts and scientists, works on discovering HIV vaccine candidates. Through the grant, the Emory research team, led by Bali Pulendran, will be able to optimize the TLR nanoparticle approach for an HIV vaccine and to test the vaccine. The research involves creating nanoparticles that mimic viruses and are covered with molecules that activate Toll-like receptors (TLRs). The nanoparticles stimulate long-lasting immune responses to inactivated influenza virus when used in mice. The Bill & Melinda Gates Foundation started the CAVD in 2006 and has funded 30 grants supporting investigators in 19 countries.

Back to other news for September 2012

Excerpted from:
FierceVaccines
09.20.2012; Alison Bryant




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/69173/georgia-emory-snags-6m-for-hivaids-vaccine-researc.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.